Glenn L. Cooper
Presidente presso Lascaux Media LLC
Profilo
Glenn L.
Cooper is currently the Chairman of Lascaux Media LLC.
He previously served as the Chairman & CEO of Indevus Pharmaceuticals, Inc. from 1996 to 2009, President & CEO of Progenitor, Inc. from 1992 to 1994, Executive Chairman of Fortress Biotech, Inc. from 2012 to 2013, Independent Director of Repligen Corp.
from 2009 to 2020, and Independent Director of Gentium Srl from 2009 to 2013.
He also served as the Director of Clinical Research at Lilly Research Center Ltd.
from 1987 to 1990.
Additionally, he was the COO & Executive VP of Sphinx Pharmaceuticals Corp.
Dr. Cooper received his undergraduate degree from Harvard College and his doctorate from Tufts University School of Medicine.
Posizioni attive di Glenn L. Cooper
| Società | Posizione | Inizio |
|---|---|---|
| Lascaux Media LLC | Presidente | - |
Precedenti posizioni note di Glenn L. Cooper
| Società | Posizione | Fine |
|---|---|---|
| REPLIGEN CORPORATION | Direttore/Membro del Consiglio | 13/05/2020 |
| GENTIUM S.P.A. (ADR) | Direttore/Membro del Consiglio | 27/03/2013 |
| FORTRESS BIOTECH, INC. | Amministratore Delegato | 01/04/2011 |
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Amministratore Delegato | 01/01/2009 |
Progenitor, Inc.
 Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Presidente | 01/06/1994 |
Formazione di Glenn L. Cooper
| Harvard College | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| FORTRESS BIOTECH, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Health Technology |
| Sphinx Pharmaceuticals Corp | Health Technology |
Lilly Research Center Ltd.
 Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Health Technology |
Gentium Srl
 Gentium Srl Pharmaceuticals: MajorHealth Technology Gentium SRL manufactures and develops biopharmaceutical products. It offers discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments. The company was founded by Laura Iris Ferro and is headquartered in Villa Guardia, Italy. | Health Technology |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
| Lascaux Media LLC |
- Borsa valori
- Insiders
- Glenn L. Cooper
